MAP7D3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.502800E-01
Normal-vs-Stage2
1.020790E-01
Normal-vs-Stage3
1.826160E-01
Normal-vs-Stage4
5.371400E-01
Stage1-vs-Stage2
9.292600E-01
Stage1-vs-Stage3
8.132400E-01
Stage1-vs-Stage4
7.168800E-01
Stage2-vs-Stage3
7.786200E-01
Stage2-vs-Stage4
4.921600E-01
Stage3-vs-Stage4
5.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.153440E-01
Normal-vs-AfricanAmerican
5.307400E-01
Normal-vs-Asian
3.304200E-02
Caucasian-vs-AfricanAmerican
4.917600E-01
Caucasian-vs-Asian
7.044200E-02
AfricanAmerican-vs-Asian
1.424350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.572000E-02
Normal-vs-Female
1.894240E-01
Male-vs-Female
1.764770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.313000E-01
Normal-vs-Age(41-60Yrs)
3.240000E-01
Normal-vs-Age(61-80Yrs)
6.479900E-02
Normal-vs-Age(81-100Yrs)
5.421700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.721800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.765600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.236400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.222090E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.661810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.015800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.160300E-02
Normal-vs-Daily Drinker
8.177100E-03
Normal-vs-Weekly Drinker
4.930400E-01
Normal-vs-Occasional Drinker
6.187700E-02
Normal-vs-Social Drinker
3.197000E-01
Non Drinker-vs-Daily Drinker
4.073800E-01
Non Drinker-vs-Weekly Drinker
1.579810E-01
Non Drinker-vs-Occasional Drinker
6.077600E-01
Non Drinker-vs-Social Drinker
5.016400E-01
Daily Drinker-vs-Weekly Drinker
9.200500E-02
Daily Drinker-vs-Occasional Drinker
1.479190E-01
Daily Drinker-vs-Social Drinker
2.741000E-01
Weekly Drinker-vs-Occasional Drinker
3.658400E-01
Weekly Drinker-vs-Social Drinker
5.967200E-01
Occasional Drinker-vs-Social Drinker
7.961400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.399000E-01
Normal-vs-Grade 2
7.567400E-01
Normal-vs-Grade 3
7.279800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.034000E-01
Grade 1-vs-Grade 3
7.831400E-01
Grade 1-vs-Grade 4
7.399000E-01
Grade 2-vs-Grade 3
4.273200E-01
Grade 2-vs-Grade 4
7.567400E-01
Grade 3-vs-Grade 4
7.279800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.318010E-01
Normal-vs-NonDiabetic
6.896100E-02
Diabetic-vs-NonDiabetic
4.248400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.530100E-02
Normal-vs-NoPancreatitis
9.324200E-02
Pancreatitis-vs-NoPancreatitis
3.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.148370E-01
Normal-vs-N1
1.112800E-01
N0-vs-N1
4.515400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.920700E-03
Normal-vs-TP53-NonMutant
1.587780E-01
TP53-Mutant-vs-TP53-NonMutant
6.021500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
